PAK1 and Macrocephaly: The predicted increase in spontaneous and/or GTPase‐stimulated kinase activation would therefore be compatible with a clinical outcome of macrocephaly and intellectual disability or developmental delay and also seizures, as it is observed with known PAK1 variants located in this autoinhibitory domain.12, 13, 14